UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations

Clinical chemistry and laboratory medicine, 2009, Vol.47 (4), p.471-477

2009

Volltextzugriff (PDF)

Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris

Arteriosclerosis, thrombosis, and vascular biology, 2007-01, Vol.27 (1), p.161-167

2007

Volltextzugriff (PDF)

Reciprocal Contribution of Pentraxin 3 and C-Reactive Protein to Obesity and Metabolic Syndrome

Obesity (Silver Spring, Md.), 2010-09, Vol.18 (9), p.1871-1874

2010

Volltextzugriff (PDF)

Pitavastatin Improves Plasma Pentraxin 3 and Arterial Stiffness in Atherosclerotic Patients with Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2009, Vol.16(4), pp.490-500

2009

Volltextzugriff (PDF)

Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH)

BMC gastroenterology, 2008-11, Vol.8 (1), p.53-53, Article 53

2008

Volltextzugriff (PDF)

Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise

European journal of applied physiology, 2010-11, Vol.110 (5), p.905-913

2010

Volltextzugriff (PDF)

The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain

Thrombosis and haemostasis, 2009-09, Vol.102 (3), p.555-563

2009

Volltextzugriff (PDF)

Increased Expression of Long Pentraxin PTX3 in Inflammatory Bowel Diseases

Digestive diseases and sciences, 2008-07, Vol.53 (7), p.1910-1916

2008

Volltextzugriff (PDF)

Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophages

Cellular immunology, 2007-08, Vol.248 (2), p.86-94

2007

Volltextzugriff (PDF)

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure

The American heart journal, 2008, Vol.155 (1), p.75-81

2008

Volltextzugriff (PDF)

Plasma Pentraxin3 and Arterial Stiffness in Men With Obstructive Sleep Apnea

American journal of hypertension, 2011-04, Vol.24 (4), p.401-407

2011

Volltextzugriff (PDF)

Identification of Cystatin SN as a novel tumor marker for colorectal cancer

International journal of oncology, 2009-07, Vol.35 (1), p.33-40

2009

Volltextzugriff (PDF)

S1233 Evaluation of Long Pentraxin Ptx3 for the Inflammation Marker in the Patients with Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-207-A-207

2008

Volltextzugriff (PDF)

Abstract 577: Long Pentraxin 3: A New, Independent Marker of Mortality in Acute Chest Pain

Circulation (New York, N.Y.), 2008-10, Vol.118 (suppl_18)

2008

Volltextzugriff (PDF)

Abstract 576: The Prognostic Value of the Long Pentraxin 3 as Compared to B-Type Natriuretic Peptide and High-Sensitive C-Reactive Protein, and their Combination, as a Prognostic Marker of Mortality in Acute Chest Pain Patients

Circulation (New York, N.Y.), 2008-10, Vol.118 (suppl_18)

2008

Volltextzugriff (PDF)

Abstract P2-03-02: Clinical utility of bone scan index (BSI) for breast cancer patients with bone metastasis -Multi-institutional prospective cohort study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-03-02

2020

Volltextzugriff (PDF)

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.538-538

2023

Volltextzugriff (PDF)

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

Breast cancer research and treatment, 2023-12, Vol.202 (3), p.473-483

2023

Volltextzugriff (PDF)

Abstract PO4-01-09: The Prognostic Impact of Adjuvant Endocrine Therapy by Age for Patients with Small Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO4-01-09-PO4-01-09

2024

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(12)
Male
(11)
Middle Aged
(10)
Aged
(8)
Biological And Medical Sciences
(8)
Adult
(7)
C-Reactive Protein - Metabolism
(7)
Female
(7)
Medical Sciences
(7)
Serum Amyloid P-Component - Metabolism
(7)
Aged, 80 And Over
(5)
Biomarkers - Blood
(5)
Cardiovascular System & Cardiology
(5)
Inflammation
(5)
Fundamental And Applied Biological Sciences. Psychology
(4)
Pentraxin 3
(4)
Peripheral Vascular Disease
(4)
Predictive Value Of Tests
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations

Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris

Reciprocal Contribution of Pentraxin 3 and C-Reactive Protein to Obesity and Metabolic Syndrome

Pitavastatin Improves Plasma Pentraxin 3 and Arterial Stiffness in Atherosclerotic Patients with Hypercholesterolemia

Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH)

Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise

The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain

Increased Expression of Long Pentraxin PTX3 in Inflammatory Bowel Diseases

Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophages

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure

Plasma Pentraxin3 and Arterial Stiffness in Men With Obstructive Sleep Apnea

Identification of Cystatin SN as a novel tumor marker for colorectal cancer

S1233 Evaluation of Long Pentraxin Ptx3 for the Inflammation Marker in the Patients with Ulcerative Colitis

Abstract 577: Long Pentraxin 3: A New, Independent Marker of Mortality in Acute Chest Pain

Abstract 576: The Prognostic Value of the Long Pentraxin 3 as Compared to B-Type Natriuretic Peptide and High-Sensitive C-Reactive Protein, and their Combination, as a Prognostic Marker of Mortality in Acute Chest Pain Patients

Abstract P2-03-02: Clinical utility of bone scan index (BSI) for breast cancer patients with bone metastasis -Multi-institutional prospective cohort study

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

Abstract PO4-01-09: The Prognostic Impact of Adjuvant Endocrine Therapy by Age for Patients with Small Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer

Suchergebnisse filtern